Emergence of tularemia in France: paradigm of the Burgundy region

Int J Infect Dis. 2011 Dec;15(12):e882-3. doi: 10.1016/j.ijid.2011.08.007. Epub 2011 Oct 4.

Abstract

We report three consecutive cases of tularemia occurring in Burgundy, France, a region previously considered not endemic for tularemia. The patients presented with varied and unspecific clinical manifestations. The epidemiological circumstances, especially the mode of contamination, were not particularly suggestive of tularemia. Serological diagnosis was delayed in two cases because of the lack of significant antibody titers at the time of admission. In contrast, a diagnosis could readily be obtained in all three cases by detection of Francisella tularensis DNA from clinical samples using PCR-based methods. These cases highlight the increased incidence and geographical spread of tularemia in France, and the usefulness of real-time PCR technology for the early diagnostic confirmation of tularemia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Communicable Diseases, Emerging / diagnosis*
  • Communicable Diseases, Emerging / drug therapy
  • Communicable Diseases, Emerging / microbiology
  • DNA, Bacterial / isolation & purification
  • Doxycycline / therapeutic use
  • Early Diagnosis
  • Female
  • Fluoroquinolones / therapeutic use
  • France
  • Francisella tularensis / genetics
  • Francisella tularensis / isolation & purification*
  • Humans
  • Lymph Nodes / microbiology
  • Male
  • Middle Aged
  • Real-Time Polymerase Chain Reaction
  • Tularemia / diagnosis*
  • Tularemia / drug therapy
  • Tularemia / microbiology

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • Fluoroquinolones
  • Doxycycline